These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interleukin-19 alleviates brain injury by anti-inflammatory effects in a mice model of focal cerebral ischemia. Xie W; Fang L; Gan S; Xuan H Brain Res; 2016 Nov; 1650():172-177. PubMed ID: 27608956 [TBL] [Abstract][Full Text] [Related]
6. CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing T Rayasam A; Kijak JA; Kissel L; Choi YH; Kim T; Hsu M; Joshi D; Laaker CJ; Cismaru P; Lindstedt A; Kovacs K; Vemuganti R; Chiu SY; Priyathilaka TT; Sandor M; Fabry Z J Neuroinflammation; 2022 May; 19(1):125. PubMed ID: 35624463 [TBL] [Abstract][Full Text] [Related]
7. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Li M; Li Z; Yao Y; Jin WN; Wood K; Liu Q; Shi FD; Hao J Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E396-E405. PubMed ID: 27994144 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice. Banerjee A; Wang J; Bodhankar S; Vandenbark AA; Murphy SJ; Offner H Transl Stroke Res; 2013 Oct; 4(5):554-63. PubMed ID: 24187596 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. Luheshi NM; Kovács KJ; Lopez-Castejon G; Brough D; Denes A J Neuroinflammation; 2011 Dec; 8():186. PubMed ID: 22206506 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 treatment protected against cerebral ischemia/reperfusion injury. Zhang B; Zhang HX; Shi ST; Bai YL; Zhe X; Zhang SJ; Li YJ Biomed Pharmacother; 2019 Jul; 115():108816. PubMed ID: 31096144 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. Dong W; Li N; Gao D; Zhen H; Zhang X; Li F J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362 [TBL] [Abstract][Full Text] [Related]
13. CD38 exacerbates focal cytokine production, postischemic inflammation and brain injury after focal cerebral ischemia. Choe CU; Lardong K; Gelderblom M; Ludewig P; Leypoldt F; Koch-Nolte F; Gerloff C; Magnus T PLoS One; 2011; 6(5):e19046. PubMed ID: 21625615 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytosolic phospholipase A(2) alpha protects against focal ischemic brain damage in mice. Zhang J; Barasch N; Li RC; Sapirstein A Brain Res; 2012 Aug; 1471():129-37. PubMed ID: 22819928 [TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway. Zhang J; Wu Y; Weng Z; Zhou T; Feng T; Lin Y Brain Res; 2014 Sep; 1582():176-86. PubMed ID: 25111887 [TBL] [Abstract][Full Text] [Related]
16. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Shen X; Wang Y; Gao F; Ren F; Busuttil RW; Kupiec-Weglinski JW; Zhai Y Hepatology; 2009 Nov; 50(5):1537-46. PubMed ID: 19670423 [TBL] [Abstract][Full Text] [Related]
17. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Cao CX; Yang QW; Lv FL; Cui J; Fu HB; Wang JZ Biochem Biophys Res Commun; 2007 Feb; 353(2):509-14. PubMed ID: 17188246 [TBL] [Abstract][Full Text] [Related]
19. Regulatory Effects of Toll-like Receptor 4 Knockout on CD4 Ren Y; Wang R; Jiang L; Wang X; Feng Z; He J; He X; Du G Ann Clin Lab Sci; 2020 Nov; 50(6):761-768. PubMed ID: 33334791 [TBL] [Abstract][Full Text] [Related]